1.
|
Phase: Phase IV Type: Supportive care Status: Completed Age: 15 and under Sponsor: Other Protocol IDs: 2006-02-069, NCT00336531
|
|
2.
|
Phase: Phase IV Type: Supportive care Status: Completed Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CR016597, ITR-KOR-5085, NCT01021683
|
|
3.
|
Phase: Phase IV Type: Supportive care Status: Completed Age: 18 to 65 Sponsor: Other Protocol IDs: SpoIV-CHA-IIS-0802, ITRFUN4044, NCT01198236
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 13 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P01899, NCT00044486
|
|
5.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 18 to 79 Sponsor: Pharmaceutical / Industry Protocol IDs: CR014299, JK1211-JPN-07, NCT00784368
|
|
6.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 13 and over Sponsor: NCI, Other Protocol IDs: 1322.00, FHCRC-1322.00, NCI-H99-0030, CDR0000067050, NCT00003883
|
|
7.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: MSKCC-02021, NOVARTIS-CPKC412A2104, NCI-G02-2107, UCLA-0305058-01, NCT00045578
|
|
8.
|
Phase: Phase II Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: J0932, JHMI-IRB number: NA_00027099, NCT00887458
|
|
9.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Temporarily closed Age: 18 and over Sponsor: Other Protocol IDs: SKIN0004, SU-04162010-5722, NCT01108094
|
|
10.
|
Phase: No phase specified Type: Supportive care Status: Closed Age: 16 and over Sponsor: Protocol IDs: EORTC-19911
|
|
11.
|
Phase: No phase specified Type: Supportive care Status: Closed Age: 12 and over Sponsor: NCI, Other Protocol IDs: CDR0000355116, UCLA-0307071, NCT00079222
|
|
12.
|
Phase: No phase specified Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 0809-10; IUCRO-0239, NCT00798135
|
|
13.
|
Phase: No phase specified Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CR015691, NCT01060462
|